The Board of directors of Shukra Pharmaceuticals Limited has recommended a Final Dividend of Rs. 0.01/- (1%) per equity share of Re 1/- each fully paid (subject to deduction of tax, if any) for the financial year 2025-26. This shall be paid subject to the approval of the sharcholders at the ensuing Annual General Meeting of the Company.